Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart Failure (NYHA Class III-IV)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The purpose of this clinical study is to evaluate the efficacy and safety of intramyocardial injection of human induced pluripotent stem cell-derived cardiomyocyte injection (HiCM-188) in patients with advanced heart failure (NYHA Class III-IV)
Epistemonikos ID: ec659ca64fa38bbb6c08a817eb7300342fc0d7e8
First added on: Mar 28, 2026